3.1.3.75	medicine	may have implications for the diagnosis of hypophosphatasia and treatment of bone mineralization abnormalities such as osteomalacia and pathological soft-tissue ossification, a process clinically significant in atheroscleosis and heart failure	654549	
3.1.3.75	medicine	PHOSPHO1 plays a role in the initiation of matrix mineralization	680993	
3.1.3.75	medicine	role in the early stages of matrix mineralization	678951